Risk of Breast Cancer Associated with Estrogen DNA Adduct Biomarker.
Kerryn W RedingClaire J HanDale WhittingtonMuhammad ZahidEleanor G RoganDale LangfordThomas E RohanRowan T ChlebowskiTing-Yuan David ChengWendy E BarringtonLesley F TinkerPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
This analysis, conducted prospectively within postmenopausal women in the WHI study, suggests that a strong association between EDA:EMC and breast cancer could be ruled out, as this study was powered to detect an OR of 2.2 or greater.